BY Maria Outze
-
Expanding promising Leo Pharma product will be new SVP’s main task
In 2026, Marika Murto signs up with Leo Pharma’s exec board with duty for international item method, where she will certainly be charged with safeguarding development for the…
-
Takeda reports positive data for psoriasis treatment
Japanese Takeda intends to look for FDA authorization for its psoriasis therapy in 2026.
-
Investor predicts success for two biotech companies in 2026
Profile supervisor at Norway’s biggest financial institution, DNB, anticipates a stock exchange upturn for both biotech firms Disc Medication and UCB following year.
-
US commission warns that China may soon take the lead in biotech
The United States has much less time than anticipated to preserve its leading placement over China in biotechnology, according to an evaluation by a United States legislative payme…
-
The hunt is on for a top executive for a new innovation district
According to headhunter Per Christensen, who is responsible for recruitment, this will not be a “classic CEO role.”
-
Major industry players welcome EU’s “crucial” plan for clinical trials
The European Compensation is acting to attend to the decrease in scientific tests in Europe. Sector organizations see the actions as “important to boosting the EU’s com…
-
Hitherto undecribed shareholding could help GN out of debt crisis
GN has a 19% risk in an expanding United States business. This might lead to a billion-dollar earnings for the listening device producer, creates InsideBusiness.
-
FDA considers changes to early trials to win race against China
At the exact same time, the United States Fda (FDA) is suggesting that even more real-world information be consisted of in future medication applications.
-
Investors pass judgment on Leo Pharma’s stock market prospects: “There will be some trembling of hands”
Leo Pharma gets on track for an IPO following year, according to numerous financiers. Nevertheless, the firm encounters a difficulty in persuading financiers: “They have a to…
-
Leo Pharma taps Amgen executive as new SVP of Global Product Strategy
Beginning in 2026, Marika Murto will certainly head Leo Pharma’s worldwide item method as the firm approaches an IPO.
